Heilongjiang Cancer Center
2012–As Heilongjiang Cancer Center, it undertakes province-wide cancer control, screening and standardized care, serving Northeast Asia.

Grade-A Tertiary Cancer Specialty Hospital
Established
1972
Beds
3,000+
Annual Volume
80,000+
Harbin
The largest cancer specialty hospital in Northeast China; President Zhang Qing-Yuan leads medical breast oncology, serving international patients across Northeast Asia.
Harbin Medical University Cancer Hospital (Heilongjiang Cancer Hospital / Heilongjiang Cancer Center) is the largest Grade-A tertiary cancer specialty hospital in Northeast China, responsible for cancer control, screening and standardized care across Heilongjiang, and serving Northeast Asia.
The hospital features medical breast oncology led by President Prof. Zhang Qingyuan, alongside complete disciplinary coverage of GI and hematologic-lymphoid tumors.
01Core of Northeast China cancer control
As Heilongjiang Cancer Center, it leads regional screening, referral and standardized care, with one of the highest patient volumes in the Northeast.
02A hub for medical breast oncology
Prof. Zhang Qingyuan’s team leads the region in neoadjuvant, targeted and immunotherapy-based comprehensive care, driving full-course breast cancer management.
03International patient services for Northeast Asia
Leveraging geographic and language advantages, it connects patients from the Russian Far East and Northeast Asia to evaluation, admission and follow-up.
As Heilongjiang Cancer Center, it undertakes province-wide cancer control, screening and standardized care, serving Northeast Asia.
The hospital’s scale and annual patient volume lead cancer specialty hospitals in Northeast China, with medical breast oncology led by Prof. Zhang Qingyuan.